Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". Circulation. 2016 Jul 12;134(2):e5-6 Authors: Imprialos K, Boutari C, Stavropoulos K PMID: 27400901 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/27400901?dopt=Abstract

Source: Circulation - July 11, 2016 Category: Cardiology Authors: Imprialos K, Boutari C, Stavropoulos K Tags: Circulation Source Type: research

More News: Atrial Fibrillation | Cardiology | Coumadin | Stroke | Warfarin